However, a combination of aspirin and metformin reportedly increased the levels of TGFβ1 and tumor-suppressor properties of TGFβ1 in 4T1 mouse breast cancer cells and reduced cell viability and induced cell death in these cells [259]. The gene discussed is TGFB1; the disease is breast cancer.